Oncology PracticeBreast cancer risk in type 2 diabetes related to adiposityOctober 1, 2018Breast CancerPreventive Care
Oncology PracticeBreast cancer patients getting unnecessary scans against recommendationsSeptember 28, 2018Breast CancerPatient & Survivor Care
Oncology PracticeMetastatic breast cancer lesions immunologically depleted compared with primarySeptember 17, 2018Breast CancerMetastatic Breast Cancer
Oncology PracticeOutcomes similar for concurrent versus sequential treatment in HER2-positive breast cancersSeptember 10, 2018Breast Cancer
Oncology PracticeTop cancer researcher fails to disclose corporate financial ties in major research journalsSeptember 10, 2018Breast Cancer
Oncology PracticeESMO scale offers guidance on cancer targetsSeptember 6, 2018Lung CancerBreast CancerPatient & Survivor CareMelanomaGastroenterologyGastrointestinal Cancer
The Journal of Community and Supportive OncologyNeratinib extends adjuvant treatment of patients with HER2-positive breast cancerAugust 26, 2018Breast Cancer
The Journal of Community and Supportive OncologyMeeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
Oncology PracticeVariants in five genes signal TNBC riskAugust 14, 2018Breast CancerPatient & Survivor Care
Oncology PracticeHerceptin linked to doubling of HF risk in women with breast cancerAugust 6, 2018Breast CancerPatient & Survivor CarePreventive Care
Oncology PracticeCTCs linked to late recurrence in HER2–, HR+ breast cancerJuly 28, 2018Breast CancerMixed Topics
Oncology PracticeLower CTC count IDs indolent MBC disease subsetJuly 27, 2018Breast CancerMetastatic Breast Cancer
Oncology PracticeBreast cancer patients don’t get the financial counseling they want from their cliniciansJuly 23, 2018Breast Cancer
